Axoltis Pharma announces to attend the 15th International Conference on Alzheimer’s & Parkinson’s Diseases (AP/PD 2021) (digital on March9-14th 2020). Axoltis Pharma preclinical reseach team is proud to present 3 posters (#P193, #P594, #P625) demonstrating the efficacy of its innovative drug candidate, a SCO-spondin derived peptide, in Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and excitotoxicity.